The London School of Hygiene and Tropical Medicine in the UK recently issued a communiqué saying that a randomized controlled trial in which the university participated found that introducing artificial intelligence technology into diabetic retinopathy screening helps shorten the time from screening to specialist treatment, and can help more patients in need of further ophthalmology to seek medical treatment in a timely manner. The relevant research paper has been published in the British “The Lancet - Global Health” magazine.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.